Rawad Abbas, Ahmad Sweid, Mohamed M Salem, Elias Atallah, Kareem El Naamani, Abdelaziz Amllay, Georgios S Sioutas, Abhijeet Sambangi, Clifford J Yudkoff, Jaime Dougherty, Joshua H Weinberg, Jad El-Hajj, Abdulaziz Alhussein, Ruyof Alhussein, Nabeel A Herial, Stavropoula Tjoumakaris, M Reid Gooch, Hekmat Zarzour, Richard F Schmidt, Robert H Rosenwasser, Pascal Jabbour
OBJECTIVE: By providing a more physiological approach to the treatment of intracranial aneurysms, the Pipeline embolization device (PED) has revolutionized the endovascular treatment of aneurysms. Although there are many flow diverters on the market, the authors report their experience with the PED, the first flow diverter to be approved by the Food and Drug Administration. They aimed to assess the efficacy and safety of PED flow diversion for the treatment of a wide range of aneurysms, as well as to look at factors affecting occlusion...
January 5, 2024: Journal of Neurosurgery